Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (724) Arrow Down
Filter Results: (724) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (949)
    • People  (2)
    • News  (121)
    • Research  (724)
    • Events  (14)
    • Multimedia  (1)
  • Faculty Publications  (401)

Show Results For

  • All HBS Web  (949)
    • People  (2)
    • News  (121)
    • Research  (724)
    • Events  (14)
    • Multimedia  (1)
  • Faculty Publications  (401)
← Page 25 of 724 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • Article

Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii

By: Michel Anteby, Filiz Garip, Paul V. Martorana and Scott Lozanoff

Background: Human cadavers are crucial to numerous aspects of health care, including initial and continuing training of medical doctors and advancement of medical research. Concerns have periodically been raised about the limited number of whole body... View Details

Keywords: Decisions; Health Care and Treatment; Personal Characteristics; Philanthropy and Charitable Giving; Health Industry; Hawaii
Citation
Read Now
Related
Anteby, Michel, Filiz Garip, Paul V. Martorana, and Scott Lozanoff. "Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii." PLoS ONE 7, no. 8 (August 2012). (e42673. doi:10.1371/journal.pone.0042673.)
  • 11 Sep 2019
  • Research & Ideas

Germany May Have the Answer for Reducing Drug Prices

to prove that a new medication’s benefits merit a higher price if cheaper, similar drugs are available. The process rewards companies whose drugs are more novel or help patients more, while forcing manufacturers of equally or less View Details
Keywords: by Danielle Kost; Health
  • 22 Jul 2019
  • Book

How to Be a Digital Platform Leader

research, you identified 209 platform failures between 1995 and 2015 and about 45 successful firms for the same period. What are drivers of success? Yoffie: The most important driver of success is network effects. Network effects create... View Details
Keywords: by Martha Lagace
  • 13 Jan 2003
  • Research & Ideas

Making Biotech Work as a Business

create safer and more effective treatments and, of course, reap profits—industry executives, like hopeful patients, still restlessly wait for relief. Given its scientific potential, said Pisano, biotech... View Details
Keywords: by Martha Lagace; Biotechnology; Health; Technology
  • 31 Oct 2004
  • Research & Ideas

Bypass Marketing: Are Docs Influenced?

drugs? How frequently do physicians prescribe advertised drugs when other drugs or treatments may be equally effective? We surveyed a national probability sample of 643 physicians practicing in a wide variety of specialties. Data were... View Details
Keywords: by Manda Salls
  • 28 Nov 2011
  • Research & Ideas

Rethinking the Fairness of Organ Transplants

only treatments are maintenance dialysis and kidney transplantation. The former requires visits to a treatment center for at least 12 hours a week, while a transplant—from either a living family member or a... View Details
Keywords: by Dennis Fisher; Health
  • 12 Jul 2020
  • Research & Ideas

Solving COVID'S Mental Health Crisis

iPhoto COVID-19 is having a devastating effect on the emotional, psychological, and social well-being (as well as the physical health) of people around the world. Risk factors for addiction, mental illness, and “deaths of despair” are... View Details
Keywords: by Howard Stevenson and Shirley Spence; Health
  • 22 May 2020
  • In Practice

Post-COVID Health Care: More Screens, Less Red Tape?

disease William A. Sahlman: New treatment options for the next pandemic The crisis reveals the remarkable progress over the past 20 years in health science. There are hundreds of companies, big and small, working on better tests, better... View Details
Keywords: by Danielle Kost
  • 15 Jan 2018
  • Research & Ideas

A Better Business Model for Fighting Cancer

therapies has become a reality, as have immunotherapies that induce or suppress a body’s immune response to treat disease. Yet, this relatively swift progress has not been fast enough for millions of other patients who still lack View Details
Keywords: by Julia Hanna; Health; Pharmaceutical
  • 19 May 2015
  • First Look

First Look: May 19

dominance, with income. Given familiar functional form assumptions on utility and the distributions of ability and preferences, a simple statistic for the effect of preference heterogeneity on marginal tax... View Details
Keywords: Sean Silverthorne
  • 12 Dec 2017
  • First Look

New Research and Ideas, December 12, 2017

demand and the profitability to engage in exports and R&D, thereby relaxing borrowing constraints and enabling more firms to overcome the fixed-cost hurdle for financing R&D. We decompose the effects of RER changes on productivity... View Details
Keywords: Sean Silverthorne
  • 09 Jan 2018
  • First Look

First Look at New Research and Ideas, January 9, 2018

separate studies by the type of entrepreneurial behavior considered: entry into entrepreneurship, performance outcomes, and exit from entrepreneurship. This literature shows common results and many points of disagreement, reflective of the View Details
Keywords: Sean Silverthorne
  • 12 Jun 2018
  • First Look

New Research and Ideas, June 12, 2018

changes in stockouts or rebalances. We observe no evidence of learning or fatigue. Agent-level heterogeneity in the treatment effects shows that the agents who handle... View Details
Keywords: Dina Gerdeman
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

already have products on the market, as does Amgen, where Gordon M. Binder (MBA '62) served as CEO until his retirement last month (he will continue to serve as chairman through December). Amgen's Epogen (a treatment for anemia in kidney... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 23 Oct 2018
  • First Look

New Research and Ideas, October 23, 2018

September 2018 Strategy Science Applying Random Coefficient Models to Strategy Research: Identifying and Exploring Firm Heterogeneous Effects By: Alcácer, Juan, Wilbur Chung, Ashton Hawk, and Gonçalo... View Details
Keywords: Dina Gerdeman
  • 13 Aug 2024
  • Op-Ed

Can AI Save Physicians from Burnout?

documentation, litigation defense, and regulatory compliance. These excessive documentation requirements also strain the patient-physician relationship, reducing the time patients spend with their doctors and hampering effective... View Details
Keywords: by Susanna Gallani, Lidia Moura, and Katie Sonnefeldt; Health
  • 12 Jul 2016
  • First Look

July 12, 2016

significant heterogeneity across countries and drug classes in all of these outcomes. While we observe that effective buyer institutions (in particular, committed tenders) are associated with increased... View Details
Keywords: Sean Silverthorne
  • 04 Oct 2016
  • First Look

October 4, 2016

private information is directionally strong, managers, at announcement, provide guidance and use language that points statistically in the opposite direction. This effect is more pronounced when, post-announcement, management insiders... View Details
  • 09 Jul 2024
  • Research & Ideas

Are Management Consulting Firms Failing to Manage Themselves?

large research and practice infrastructures to produce in-depth insights for a staggering array of public companies, private entities, investment firms, public sector organizations, academic institutions, not-for-profits, and governmental clients. “This created View Details
Keywords: by David Fubini; Consulting
  • 12 Jul 2004
  • Research & Ideas

Michael Porter’s Prescription For the High Cost of Health Care

right kind of competition working. The health care system can achieve stunning gains in quality and efficiency. And employers, the major purchasers of health care services, could lead the transformation. [ ] Positive-sum Competition In a healthy system, competition at... View Details
Keywords: by Michael E. Porter; Health
  • ←
  • 25
  • 26
  • …
  • 36
  • 37
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.